Catalent (CTLT) to Hold Business Update Call Related to Delay of Third Quarter 2023 Results and Receives NYSE Notice Regarding Late Form 10-Q Filing

Go back to Catalent (CTLT) to Hold Business Update Call Related to Delay of Third Quarter 2023 Results and Receives NYSE Notice Regarding Late Form 10-Q Filing

Catalent (CTLT) declines again after cutting guidance

May 19, 2023 8:15 AM EDT

Shares of drug manufacturer Catalent (NYSE: CTLT) declined Friday morning after telling investors it will provide a business update today instead of a normal review of its third quarter results. This was the third time Catalent delayed the earnings release, once again citing problems with accounting adjustments.

Catalent... More

Catalent (CTLT) Lowers FY23 Revenue Guidance

May 19, 2023 7:16 AM EDT

Catalent (NYSE: CTLT) Sees FY23 Revenue of $4.25B to $4.35B vs Consensus $4.44B (Prior $4.625B -$4.875B)

Adjust EBITDA $725M to $775MAdj. Net Income $187M to $228M
... More